Literature DB >> 19164921

Spatial signaling networks converge at the adaptor protein Shc.

Daniel Timothy Sweet1, Ellie Tzima.   

Abstract

Endothelial cells, which are located at the interface between the blood and the vessel wall, respond dynamically to a variety of stimuli initiating signaling cascades that regulate cardiovascular development, physiology and pathology. These inputs include soluble factors that bind to their receptors, integrin-matrix interactions, cell-cell contacts and mechanical forces due to the flowing blood. While these stimuli can mediate unique downstream signals, it is well-accepted that signaling pathways are highly interwoven into complex signaling networks with several levels of cross-talk, integration and coordination. Recent studies suggest that several signaling networks coalesce at the adaptor protein Shc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164921      PMCID: PMC2952394          DOI: 10.4161/cc.8.2.7383

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  67 in total

1.  The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation.

Authors:  Mélanie Laramée; Catherine Chabot; Monikca Cloutier; Raphaëlle Stenne; Marina Holgado-Madruga; Albert J Wong; Isabelle Royal
Journal:  J Biol Chem       Date:  2006-12-17       Impact factor: 5.157

2.  The adaptor protein Shc couples a class of integrins to the control of cell cycle progression.

Authors:  K K Wary; F Mainiero; S J Isakoff; E E Marcantonio; F G Giancotti
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

3.  Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.

Authors:  Y Chen; D Grall; A E Salcini; P G Pelicci; J Pouysségur; E Van Obberghen-Schilling
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

4.  A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.

Authors:  G Pelicci; L Dente; A De Giuseppe; B Verducci-Galletti; S Giuli; S Mele; C Vetriani; M Giorgio; P P Pandolfi; G Cesareni; P G Pelicci
Journal:  Oncogene       Date:  1996-08-01       Impact factor: 9.867

5.  Angiotensin II type 2 receptor-dependent increases in nitric oxide synthase expression in the pulmonary endothelium is mediated via a G alpha i3/Ras/Raf/MAPK pathway.

Authors:  Jianyu Li; Xiangmin Zhao; Xinmei Li; Kenneth M Lerea; Susan C Olson
Journal:  Am J Physiol Cell Physiol       Date:  2007-02-28       Impact factor: 4.249

6.  Evidence for a physical association between the Shc-PTB domain and the beta c chain of the granulocyte-macrophage colony-stimulating factor receptor.

Authors:  J C Pratt; M Weiss; C A Sieff; S E Shoelson; S J Burakoff; K S Ravichandran
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

7.  Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells.

Authors:  P Klint; S Kanda; L Claesson-Welsh
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

8.  Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system.

Authors:  G Breier; F Breviario; L Caveda; R Berthier; H Schnürch; U Gotsch; D Vestweber; W Risau; E Dejana
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

9.  Signal transduction by the alpha 6 beta 4 integrin: distinct beta 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes.

Authors:  F Mainiero; A Pepe; K K Wary; L Spinardi; M Mohammadi; J Schlessinger; F G Giancotti
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

10.  Shc coordinates signals from intercellular junctions and integrins to regulate flow-induced inflammation.

Authors:  Yunhao Liu; Daniel Timothy Sweet; Mohamad Irani-Tehrani; Nobuyo Maeda; Ellie Tzima
Journal:  J Cell Biol       Date:  2008-07-07       Impact factor: 10.539

View more
  7 in total

1.  The adaptor protein Shc integrates growth factor and ECM signaling during postnatal angiogenesis.

Authors:  Daniel Timothy Sweet; Zhongming Chen; David M Wiley; Victoria L Bautch; Ellie Tzima
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

Review 2.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

3.  Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli.

Authors:  Kin Man Suen; Chi-Chuan Lin; Roger George; Fernando A Melo; Eleanor R Biggs; Zamal Ahmed; Melanie N Drake; Swathi Arur; Stefan T Arold; John E Ladbury
Journal:  Nat Struct Mol Biol       Date:  2013-04-14       Impact factor: 15.369

4.  Endothelial Shc regulates arteriogenesis through dual control of arterial specification and inflammation via the notch and nuclear factor-κ-light-chain-enhancer of activated B-cell pathways.

Authors:  Daniel T Sweet; Zhongming Chen; Christopher S Givens; A Phillip Owens; Mauricio Rojas; Ellie Tzima
Journal:  Circ Res       Date:  2013-05-09       Impact factor: 17.367

5.  Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling.

Authors:  Chi-Chuan Lin; Kin Man Suen; Amy Stainthorp; Lukasz Wieteska; George S Biggs; Andrei Leitão; Carlos A Montanari; John E Ladbury
Journal:  Cancer Lett       Date:  2019-05-14       Impact factor: 8.679

Review 6.  Endothelial Mechanosignaling: Does One Sensor Fit All?

Authors:  Chris Givens; Ellie Tzima
Journal:  Antioxid Redox Signal       Date:  2016-03-30       Impact factor: 8.401

7.  Mechanical forces regulate endothelial-to-mesenchymal transition and atherosclerosis via an Alk5-Shc mechanotransduction pathway.

Authors:  Vedanta Mehta; Kar-Lai Pang; Christopher S Givens; Zhongming Chen; Jianhua Huang; Daniel T Sweet; Hanjoong Jo; John S Reader; Ellie Tzima
Journal:  Sci Adv       Date:  2021-07-09       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.